Small fiber neuropathies: expanding their etiologies.

Abstract

PURPOSE OF REVIEW:

Several conditions have been associated with the development of small fiber neuropathy (SFN). The list of metabolic, immune-mediated, infectious, toxic, drugs-related, and hereditary conditions is still growing and various hypotheses are made about the underlying pathophysiological mechanisms. Understanding these processes is important to provide new targets for treatment. In addition, the specific SFN phenotype can provide direction for the underlying etiology. This review discusses the latest developments concerning the expanding etiologies in SFN.

RECENT FINDINGS:

In the past 18 months, special attention has been paid to immunological etiologies, partly due to the coronavirus disease 2019 pandemic, but also new auto-antibodies in SFN have been demonstrated. Identifying patients with immune-mediated SFN can be challenging, since contrary to the classical distal sensory phenotype, a nonlength-dependent pattern is more common.Besides the etiologies of classical SFN, small fiber pathology is increasingly described in diseases without the typical neuropathic pain features of SFN, sometimes called syndromic SFN. However, the clinical relevance is not yet fully understood.

SUMMARY:

The expansion of the etiologies of SFN continues and brings more insight in possible targets for treatment. The clinical presentation may vary as a result of the underlying condition.

• Authors: Janneke G J Hoeijmakers, Ingemar S J Merkies, Catharina G Faber
• Journal: Current opinion in neurology (Curr Opin Neurol) Vol. 35 Issue 5 Pg. 545-552 (10 01 2022) ISSN: 1473-6551 [Electronic] England
• PMID: 35950732 (Publication Type: Journal Article, Review)
• Copyright: Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Chemical References

• Antibodies

Topics

• Antibodies
• COVID-19 (complications)
• Humans
• Neuralgia (etiology, therapy)
• Small Fiber Neuropathy (etiology, pathology)